专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20070167632A1 Method for synthesizing compound and catalyst for synthesis reaction 失效
标题翻译：合成化合物的方法和合成反应的催化剂
公开(公告)号：US20070167632A1
公开(公告)日：2007-07-19
申请号：US11587340
申请日：2006-04-25
申请人： Steven Ley , Martin Smith , Sophie Lohmann , Steven Andrews , J. Attfield , Hirohisa Tanaka , Kimiyoshi Kaneko
发明人： Steven Ley , Martin Smith , Sophie Lohmann , Steven Andrews , J. Attfield , Hirohisa Tanaka , Kimiyoshi Kaneko
IPC分类号： C07D213/06 , B01J23/00 , C07C6/12
CPC分类号： B01J23/002 , B01J23/63 , B01J23/6562 , B01J23/894 , B01J23/8986 , B01J2523/00 , C07C2/861 , C07C17/266 , C07C49/78 , C07C201/12 , C07C2523/10 , C07C2523/44 , C07C2523/72 , C07C2523/745 , C07D333/10 , C07C15/54 , C07C25/24 , B01J2523/17 , B01J2523/3706 , B01J2523/824 , B01J2523/842 , B01J2523/36 , B01J2523/3725 , B01J2523/24 , B01J2523/3718 , B01J2523/72 , B01J2523/845 , C07C205/35
摘要： To provide a catalyst for synthesis reaction which can achieve good yield in the Sonogashira reaction and also can be recovered after the reaction, and a method for synthesizing a compound in which the catalyst for synthesis reaction is used, a perovskite-type composite oxide containing palladium is used as the catalyst for synthesis reaction in the Sonogashira reaction represented by the following reaction scheme (1): R1—X+HC≡CR2→R1C≡CR2 (1)
摘要翻译：为了提供合成反应的催化剂，其能够在Sonogashira反应中获得良好的产率，并且也可以在反应后回收，以及合成其中使用合成反应的催化剂的化合物的方法，含有钯的钙钛矿型复合氧化物用作由以下反应方案（1）表示的Sonogashira反应中的合成反应的催化剂：<？in-line-formula description =“In-line formula”end =“lead”？> R＆lt; 1＆ / SUB + -X +HC≡CR2 - > R 1C≡CR2（1）<β在线公式描述 =“内联公式”end =“tail”？>

2. 发明授权

US07476750B2 Method for synthesizing compound and catalyst for synthesis reaction 失效
标题翻译：合成化合物的方法和合成反应的催化剂
公开(公告)号：US07476750B2
公开(公告)日：2009-01-13
申请号：US11587340
申请日：2006-04-25
申请人： Steven V. Ley , Martin D. Smith , Sophie Lohmann , Steven P. Andrews , J. Paul Attfield , Hirohisa Tanaka , Kimiyoshi Kaneko
发明人： Steven V. Ley , Martin D. Smith , Sophie Lohmann , Steven P. Andrews , J. Paul Attfield , Hirohisa Tanaka , Kimiyoshi Kaneko
IPC分类号： C07F17/02 , C07C5/08
CPC分类号： B01J23/002 , B01J23/63 , B01J23/6562 , B01J23/894 , B01J23/8986 , B01J2523/00 , C07C2/861 , C07C17/266 , C07C49/78 , C07C201/12 , C07C2523/10 , C07C2523/44 , C07C2523/72 , C07C2523/745 , C07D333/10 , C07C15/54 , C07C25/24 , B01J2523/17 , B01J2523/3706 , B01J2523/824 , B01J2523/842 , B01J2523/36 , B01J2523/3725 , B01J2523/24 , B01J2523/3718 , B01J2523/72 , B01J2523/845 , C07C205/35
摘要： To provide a catalyst for synthesis reaction which can achieve good yield in the Sonogashira reaction and also can be recovered after the reaction, and a method for synthesizing a compound in which the catalyst for synthesis reaction is used, a perovskite-type composite oxide containing palladium is used as the catalyst for synthesis reaction in the Sonogashira reaction represented by the following reaction scheme (1): R1—X+HC≡CR2→R1C≡CR2 (1)
摘要翻译：为了提供合成反应的催化剂，其能够在Sonogashira反应中获得良好的产率，并且也可以在反应后回收，以及合成其中使用合成反应的催化剂的化合物的方法，含有钯的钙钛矿型复合氧化物用作由以下反应方案（1）表示的Sonogashira反应中的合成反应的催化剂：<？in-line-formula description =“In-line Formulas”end =“lead”？> R1-X +HC≡ CR2->R1C≡CR2（1）<？in-line-formula description =“In-line Formulas”end =“tail”？>

3. 发明申请

US20120309791A1 NOVEL COMPOUND FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS 有权
标题翻译：用于治疗与淀粉样蛋白或类淀粉样蛋白相关的疾病的新型化合物
公开(公告)号：US20120309791A1
公开(公告)日：2012-12-06
申请号：US13557770
申请日：2012-07-25
申请人： Wolfgang FROESTL , Nampally Sreenivasachary , Sophie Lohmann , Maria Pilar Lopez Deber , Andreas MUHS , Maria Pihlgren Bosch
发明人： Wolfgang FROESTL , Nampally Sreenivasachary , Sophie Lohmann , Maria Pilar Lopez Deber , Andreas MUHS , Maria Pihlgren Bosch
IPC分类号： G01N33/566 , A61K31/444 , C07D401/12 , A61K31/4439 , C07D417/14 , C07D409/14 , A61P27/02 , A61P27/12 , A61P27/06 , A61P25/00 , A61P25/28 , A61P25/16 , A61P3/10 , A61P35/00 , A61P9/00 , C07D401/14
CPC分类号： C07D401/12 , C07D213/74 , C07D213/75 , C07D231/38 , C07D277/42 , C07D403/12 , C07D405/04 , C07D409/14 , C07D417/12 , C07D417/14
摘要： The present invention relates to novel compounds of formula (II) that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating, or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed
摘要翻译：本发明涉及新的式（II）化合物，其可用于治疗与淀粉样蛋白（例如阿尔茨海默病）相关的一组疾病和异常以及与淀粉状蛋白样蛋白相关的疾病或病症。本发明的化合物还可以用于治疗与视觉系统的组织中的病理学异常/变化相关的眼部疾病。本发明还涉及包含这些化合物的药物组合物和这些化合物用于制备用于治疗或预防与淀粉样蛋白和/或淀粉样蛋白样蛋白相关的疾病或病症的药物的用途。还公开了治疗或预防与淀粉样蛋白和/或淀粉样蛋白样蛋白相关的疾病或病症的方法

4. 发明申请

US20100144793A1 NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS 审中-公开
标题翻译：用于治疗与淀粉样蛋白或类淀粉样蛋白相关的疾病的新型化合物
公开(公告)号：US20100144793A1
公开(公告)日：2010-06-10
申请号：US12516167
申请日：2007-11-23
申请人： Wolfgang Froestl , Nampally Sreenivasachary , Sophie Lohmann , Maria Pilar Lopez Deber , Andreas Muhs , Maria Pihlgren Bosch
发明人： Wolfgang Froestl , Nampally Sreenivasachary , Sophie Lohmann , Maria Pilar Lopez Deber , Andreas Muhs , Maria Pihlgren Bosch
IPC分类号： A61K31/444 , C07D403/12 , C07D401/14 , A61K31/4155 , G01N33/53 , A61P25/28
CPC分类号： C07D405/14 , C07D231/38 , C07D231/40 , C07D231/56 , C07D243/02 , C07D243/12 , C07D401/14 , C07D409/14
摘要： The present invention relates to compounds of the general formula (I) wherein (formula 2) independently represents a single bond or a double bond, represents a linking group A and A′ are each independently a 5- to 7-membered heterocyclic ring, wherein the heterocyclic rings A und A′ are optionally substituted by one or more substituents, selected from C1-6 alkyl, C3-6 cycloalkyl, optionally substituted phenyl, optionally substituted heteroaryl, C1-4 alkylene-(optionally substituted phenyl) and C1-4 alkylene-(optionally substituted heteroaryl), or two substituents may be joined to form an optionally substituted, saturated, unsaturated or aromatic 5- to 7-membered ring which is fused with the heterocyclic ring A or A′, and wherein the heterocyclic rings A und A′ may contain in addition to the units X, X′, Y and Y′ one or more heteroatoms, selected from N, NR, S and Ol wherein R is selected from H and C1-4 alkyl; the units X and X′ are each independently a H-bond acceptor; and the units Y and Y′ are each independently a H-bond donor. The compound of formula (I) can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system.
摘要翻译：本发明涉及通式（I）的化合物，其中（式2）独立地表示单键或双键，表示连接基团A和A'各自独立地为5-至7-元杂环，其中杂环A和A'任选被一个或多个选自C 1-6烷基，C 3-6环烷基，任选取代的苯基，任选取代的杂芳基，C 1-4亚烷基 - （任选取代的苯基）和C 1-4的取代基取代亚烷基 - （任选取代的杂芳基）或两个取代基可以连接形成与杂环A或A'稠合的任选取代的，饱和的，不饱和的或芳族的5-至7-元环，并且其中杂环A 除了单元X，X'，Y和Y'之外，还可以含有一个或多个选自N，NR，S和O的杂原子，其中R选自H和C 1-4烷基; 单元X和X'各自独立地为H键受体; 单元Y和Y'各自独立地为H键供体。式（I）化合物可用于治疗与淀粉样蛋白相关的一组疾病和异常，例如阿尔茨海默病，以及与淀粉状蛋白样蛋白相关的疾病或病症。本发明的化合物还可以用于治疗与视觉系统的组织中的病理学异常/变化相关的眼部疾病。

5. 发明授权

US08673940B2 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins 有权
标题翻译：用于治疗与淀粉样蛋白或淀粉样样蛋白相关的疾病的化合物
公开(公告)号：US08673940B2
公开(公告)日：2014-03-18
申请号：US13557770
申请日：2012-07-25
申请人： Wolfgang Froestl , Nampally Sreenivasachary , Sophie Lohmann , Maria Pilar Lopez Deber , Andreas Muhs , Maria Pihlgren Bosch
发明人： Wolfgang Froestl , Nampally Sreenivasachary , Sophie Lohmann , Maria Pilar Lopez Deber , Andreas Muhs , Maria Pihlgren Bosch
IPC分类号： A61K31/44
CPC分类号： C07D401/12 , C07D213/74 , C07D213/75 , C07D231/38 , C07D277/42 , C07D403/12 , C07D405/04 , C07D409/14 , C07D417/12 , C07D417/14
摘要： The present invention relates to novel compounds of formula (II) that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating, or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.
摘要翻译：本发明涉及新的式（II）化合物，其可用于治疗与淀粉样蛋白（例如阿尔茨海默病）相关的一组疾病和异常以及与淀粉状蛋白样蛋白相关的疾病或病症。本发明的化合物还可以用于治疗与视觉系统的组织中的病理学异常/变化相关的眼部疾病。本发明还涉及包含这些化合物的药物组合物和这些化合物用于制备用于治疗或预防与淀粉样蛋白和/或淀粉样蛋白样蛋白相关的疾病或病症的药物的用途。还公开了治疗或预防与淀粉样蛋白和/或淀粉样蛋白样蛋白相关的疾病或病症的方法。

6. 发明申请

US20100183513A1 N-(METHYL) -1H-PYRAZOL-3-AMINE, N-(METHYL)-PYRIDIN-2-AMINE AND N-(METHYL)-THIAZOL-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'S 审中-公开
标题翻译： N-（甲基）-1H-吡唑-3-胺，N-（甲基） - 吡啶-2-胺和N-（甲基） - 噻唑-2-胺衍生物，用于治疗与淀粉样蛋白或类似淀粉样相关的疾病蛋白质，如EG 老年痴呆症
公开(公告)号：US20100183513A1
公开(公告)日：2010-07-22
申请号：US12516151
申请日：2007-11-23
申请人： Wolfgang Froestl , Nampally Sreenivasachary , Sophie Lohmann , Maria Pilar Lopez Deber , Andreas Muhs , Maria Pihlgren Bosch
发明人： Wolfgang Froestl , Nampally Sreenivasachary , Sophie Lohmann , Maria Pilar Lopez Deber , Andreas Muhs , Maria Pihlgren Bosch
IPC分类号： A61K49/00 , G01N33/53 , A61K31/444 , A61K31/4439 , A61K31/427 , C07D401/12 , C07D417/14 , A61P25/16 , A61P25/00 , A61P25/28
CPC分类号： C07D401/12 , C07D213/74 , C07D213/75 , C07D231/38 , C07D277/42 , C07D403/12 , C07D405/04 , C07D409/14 , C07D417/12 , C07D417/14
摘要： The present invention relates to novel compounds of formula (II) that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating, or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.
摘要翻译：本发明涉及新的式（II）化合物，其可用于治疗与淀粉样蛋白（例如阿尔茨海默病）相关的一组疾病和异常以及与淀粉状蛋白样蛋白相关的疾病或病症。本发明的化合物还可以用于治疗与视觉系统的组织中的病理学异常/变化相关的眼部疾病。本发明还涉及包含这些化合物的药物组合物和这些化合物用于制备用于治疗或预防与淀粉样蛋白和/或淀粉样蛋白样蛋白相关的疾病或病症的药物的用途。还公开了治疗或预防与淀粉样蛋白和/或淀粉样蛋白样蛋白相关的疾病或病症的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式